Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers

Clinical trial NCT00001538 · COMPLETED

Trial details

NCT number: NCT00001538
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acquired Immunodeficiency Syndrome HIV Infection

Start date: 1996-03-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.